More From Forbes
Understanding The 'Sober Curious' Movement","scope":{"topStory":{"index":1,"title":"Understanding The 'Sober Curious' Movement","image":"https://specials-images.forbesimg.com/imageserve/659c60e2594eec6e35b8b17d/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"Jan 10, 2024","hourMinute":"12:11","amPm":"pm","isEDT":false,"unformattedDate":1704906670886},"uri":"https://www.forbes.com/sites/nicoleroberts/2024/01/10/understanding-the-sober-curious-movement/"}},"id":"76j6i9pa2lgo00"},{"textContent":"
Feds Tout Record 20.3 Million Obamacare Sign-Ups, But Medicaid Losses Loom Large","scope":{"topStory":{"index":2,"title":"Feds Tout Record 20.3 Million Obamacare Sign-Ups, But Medicaid Losses Loom Large","image":"https://specials-images.forbesimg.com/imageserve/659ec16ed07796a1284821d5/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"Jan 10, 2024","hourMinute":"11:59","amPm":"am","isEDT":false,"unformattedDate":1704905997369},"uri":"https://www.forbes.com/sites/katiejennings/2024/01/10/feds-tout-record-203-million-obamacare-sign-ups-but-medicaid-losses-loom-large/"}},"id":"aipekakgiphk00"},{"textContent":"
FDA Pushes Back On Calls For Safety Tests Of Generic Drugs","scope":{"topStory":{"index":3,"title":"FDA Pushes Back On Calls For Safety Tests Of Generic Drugs","image":"https://specials-images.forbesimg.com/imageserve/659b594e645444a3681d49ae/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"Jan 10, 2024","hourMinute":"09:57","amPm":"am","isEDT":false,"unformattedDate":1704898630836},"uri":"https://www.forbes.com/sites/arthurkellermann/2024/01/10/we-should-test-generic-drugs-to-assure-safety-the-fda-hates-the-idea/"}},"id":"fg9kprrplnd40"},{"textContent":"
Pediatricians, Don’t Hang Up Your White Coats. ChatGPT Missed 80% Of Diagnoses","scope":{"topStory":{"index":4,"title":"Pediatricians, Don’t Hang Up Your White Coats. ChatGPT Missed 80% Of Diagnoses","image":"https://specials-images.forbesimg.com/imageserve/659e229a923e798c4d2b30c5/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"Jan 10, 2024","hourMinute":"08:00","amPm":"am","isEDT":false,"unformattedDate":1704891600000},"uri":"https://www.forbes.com/sites/ninashapiro/2024/01/10/pediatricians-dont-hang-up-your-white-coats-chatgpt-missed-80-of-diagnoses/"}},"id":"2ahdqccqo1fg00"},{"textContent":"
Measles Outbreak In Philadelphia Suggests Growing Problem Of Vaccine Hesitancy","scope":{"topStory":{"index":5,"title":"Measles Outbreak In Philadelphia Suggests Growing Problem Of Vaccine Hesitancy","image":"https://specials-images.forbesimg.com/imageserve/659d5ae5c3816456de8f59c3/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"Jan 9, 2024","hourMinute":"02:41","amPm":"pm","isEDT":false,"unformattedDate":1704829275141},"uri":"https://www.forbes.com/sites/joshuacohen/2024/01/09/measles-outbreak-in-philadelphia-suggests-growing-problem-of-vaccine-hesitancy/"}},"id":"5qkfclcc5me400"},{"textContent":"
Rite Aid Sells PBM Elixir For $575M To MedImpact","scope":{"topStory":{"index":6,"title":"Rite Aid Sells PBM Elixir For $575M To MedImpact","image":"https://specials-images.forbesimg.com/imageserve/658de40ca126f302d320f089/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"Jan 9, 2024","hourMinute":"01:14","amPm":"pm","isEDT":false,"unformattedDate":1704824050393},"uri":"https://www.forbes.com/sites/brucejapsen/2024/01/09/rite-aid-sells-pbm-elixir-for-575m-to-medimpact/"}},"id":"ar9ko5e74n9o00"},{"textContent":"
Doctors Aren’t Prescribing Paxlovid Often Enough. Here’s Why","scope":{"topStory":{"index":7,"title":"Doctors Aren’t Prescribing Paxlovid Often Enough. Here’s Why","image":"https://specials-images.forbesimg.com/imageserve/659cad773b7bfb29fa919f3e/290x0.jpg","isHappeningNowArticle":false,"date":{"monthDayYear":"Jan 9, 2024","hourMinute":"12:00","amPm":"pm","isEDT":false,"unformattedDate":1704819600000},"uri":"https://www.forbes.com/sites/judystone/2024/01/09/doctors-arent-prescribing-paxlovid-often-enough-heres-why/"}},"id":"9m2lj97bhoao00"},{"textContent":"
Beyond Patching: Exploring Diverse Treatment Options For Amblyopia","scope":{"topStory":{"index":8,"title":"Beyond Patching: Exploring Diverse Treatment Options For Amblyopia","image":"https://specials-images.forbesimg.com/imageserve/659d64752b56cb679ad060e2/290x0.png","isHappeningNowArticle":false,"date":{"monthDayYear":"Jan 9, 2024","hourMinute":"10:26","amPm":"am","isEDT":false,"unformattedDate":1704813997352},"uri":"https://www.forbes.com/sites/williamhaseltine/2024/01/09/beyond-patching-exploring-diverse-treatment-options-for-amblyopia/"}},"id":"p076qpi6horg0"}],"breakpoints":[{"breakpoint":"@media all and (max-width: 767px)","config":{"enabled":false}},{"breakpoint":"@media all and (max-width: 768px)","config":{"inView":2,"slidesToScroll":1}},{"breakpoint":"@media all and (min-width: 1681px)","config":{"inView":6}}]};
